“Hepatitis b”的搜索结果，显示 401-410 项，共有 10529 项

1. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   A Dose-Escalation and Expansion Study of BGB-16673 in Participants With B-Cell Malignancies. Rochester, Minn., Jacksonville, Fla., Scottsdale/Phoenix, Ariz ...

2. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rituximab, Romidepsin, and Lenalidomide in Treating Patients With Recurrent or Refractory B-cell Non-Hodgkin Lymphoma. Rochester, Minn., Scottsdale/Phoenix ...

3. 妙佑医疗国际 - 概述

   皮肤B 细胞淋巴瘤是一种罕见癌症，始发于白细胞。这种癌症会侵袭皮肤。皮肤B 细胞淋巴瘤始发于一种称为B 细胞的抗菌白细胞。这些细胞又称为B 淋巴细胞。

4. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of this study is to evaluate the safety and tolerability of STP938 as a single agent in adult subjects with R/R B-cell and T-cell lymphomas.

5. 血液科- 临床试验- 妙佑医疗国际

   AZD0486 As Monotherapy In Participants With Relapsed/Refractory (R/R) B-cell NHL ... B-cell non-Hodgkin lymphoma (NHL) who have received at least two prior ...

6. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Patients randomized to B+R will receive 6 cycles of treatment consisting of a rituximab infusion (Cycle 1: 375 mg/m2; Cycles 2-6: 500 mg/m2) on Day 1 and ...

7. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...

8. 血液科- 临床试验- 妙佑医疗国际

   AZD0486 As Monotherapy In Participants With Relapsed/Refractory (R/R) B-cell NHL ... B-cell non-Hodgkin lymphoma (NHL) who have received at least two prior ...

9. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rituximab, Romidepsin, and Lenalidomide in Treating Patients With Recurrent or Refractory B-cell Non-Hodgkin Lymphoma. Rochester, Minn., Scottsdale/Phoenix ...

10. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...